![]() |
市場調查報告書
商品編碼
2026944
超音波設備市場預測至2034年-按產品、應用、最終用戶和地區分類的全球分析Ultrasound Equipment Market Forecasts to 2034 - Global Analysis By Product (Compact, Table Top and Other Products), Application, End User and By Geography |
||||||
根據 Stratistics MRC 預測,全球超音波診斷設備市場預計將在 2026 年達到 124 億美元,並在預測期內以 9.3% 的複合年成長率成長,到 2034 年達到 193 億美元。
利用高頻聲波產生體內影像的設備稱為超音波診斷設備。可視化肌肉、肌腱、關節、器官、組織和身體結構(包括心臟、肝臟和腎臟等內臟器官)是一種典型的醫學診斷技術。超音波設備發出聲波,聲波從體內結構反射回來產生影像,醫護人員可以利用這些影像來診斷疾病並後續觀察。
根據英國國家醫療服務系統(NHS)英格蘭分部 2021 年 12 月發布的數據,2020 年 8 月至 2021 年 8 月期間,英國約有 944 萬名 NHS 患者接受了診斷性超音波檢查。
超音波影像成像系統的技術進步
技術創新是市場發展的關鍵驅動力。超音波診斷技術的持續創新和進步正在改變整個產業。彈性成像、移動性提升、3D/4D成像以及人工智慧整合等前沿功能正在革新診斷能力,並顯著改善患者照護。這些技術進步不僅提高了診斷檢查的速度和準確性,也最佳化了治療方案的發展。
有限的還款政策
不完善的報銷機制會阻礙超音波技術的進步。較低的報銷率會限制用於醫護人員超音波設備訓練的資金。較低的報銷金額會阻礙醫療機構投資最新的超音波設備。為了降低成本,醫療機構可能會選擇較舊或技術含量較低的設備,這會對診斷的準確性和品質產生負面影響。這正在阻礙市場擴張。
人們越來越關注即時診斷(POC診斷)。
由於床邊超音波診斷(POC)的日益普及,市場正經歷顯著成長。床邊超音波診斷是指醫護人員在病人床邊使用超音波進行快速診斷和治療的方法。這些設備體積小、重量輕,通常採用電池供電,即使在條件艱苦的情況下也適用於床邊使用。這使得醫療服務能夠惠及醫療資源匱乏的地區,進而改善整體醫療服務的可近性,並滿足未被滿足的醫療需求。如今,超音波服務的普及程度比以往任何時候都更高。
高昂的維護和升級成本
超音波診斷設備的初始購置成本較高,這對於小規模醫院和發展中地區的醫院而言可能是一個主要障礙。醫療機構可能因需要升級設備以跟上技術進步和持續維護而面臨財務困難。此外,在資源有限、預算緊張的醫療機構中,超音波診斷設備的高成本也可能成為阻礙其廣泛應用的因素。
新冠疫情對整個超音波市場造成了負面影響。疫情擾亂了全球醫療設備供應鏈。一些市場上的主要公司面臨來自新興國家分銷商的供應中斷問題,這些國家受疫情衝擊尤為嚴重。同時,一些公司由於無法取得在地採購原料和零件,其生產能力也受到了影響。
在預測期內,放射科預計將成為最大的細分市場。
在預測期內,放射學領域預計將佔據最大的市場佔有率。這主要歸功於人工智慧(AI)在放射學領域的應用日益廣泛。人工智慧技術將加快並簡化超音波檢查,使更多醫護人員能夠進行基礎心臟超音波圖。該技術能夠識別高風險族群在任何地點(包括醫院、家庭和其他院外環境)的疾病症狀,例如心臟衰竭。這將有助於縮短住院時間並改善患者預後。
在預測期內,醫院產業預計將呈現最高的複合年成長率。
由於超音波設備在醫院環境中的廣泛應用,預計醫院領域在預測期內將呈現最高的複合年成長率。隨著可攜式系統的推出,門診和住院病房對超音波設備的需求預計將會增加。此外,醫院和產業內先進影像系統的日益普及併購的活性化,也將推動未來幾年新增安裝需求的成長。
在預測期內,北美預計將佔據最大的市場佔有率。該地區眾多競爭對手的存在以及癌症患者數量的不斷增加是推動區域市場成長的主要因素。醫療保健成本的上升、對各種診斷方法的深入了解以及有利的報銷政策預計也將促進區域市場的成長。
由於對高性能診斷成像設備的需求不斷成長,預計亞太地區在預測期內將保持最高的複合年成長率。此外,各大公司正採取各種策略來加強在該地區的業務。低研發成本、寬鬆的監管政策以及各國政府加大對研發領域的投入等因素,都使該地區對研發活動更具吸引力。
According to Stratistics MRC, the Global Ultrasound Equipment Market is accounted for $12.4 billion in 2026 and is expected to reach $19.3 billion by 2034 growing at a CAGR of 9.3% during the forecast period. Devices that create pictures of the inside of the body using high-frequency sound waves are referred to as ultrasound equipment. Visualizing organs, tissues, and bodily structures, including muscles, tendons, joints, and internal organs like the heart, liver, and kidneys, is a typical medical diagnostic technique. When sound waves are emitted by ultrasound devices and bounce off inside structures, pictures are produced that medical practitioners can use to diagnose ailments or track the course of diseases.
According to a data published by NHS England in December 2021, around 9.44 million NHS patients in the U.K., underwent diagnostic ultrasonography from August 2020 to August 2021.
Technological advancements in ultrasound imaging systems
Innovations in technology are key factors driving the market. Due to ongoing innovation and advancements in ultrasonography technology, the industry is undergoing a major change. Cutting-edge features including elastography, improved mobility, 3D/4D imaging, and AI integration are transforming diagnostic capabilities and greatly enhancing patient care. These technological advancements improve treatment planning in addition to improving diagnostic tests speed and accuracy.
Limited reimbursement policies
Insufficient reimbursement might hinder the advancement of ultrasound technologies. Decreased reimbursement rates may restrict the amount of funds allotted for ultrasound equipment training for medical personnel. Lower reimbursement might deter medical institutions from investing in the newest ultrasound equipment. To save money, they can choose to use outdated or less sophisticated technology, which would affect the precision and caliber of diagnosis. This is the aspect preventing the market from expanding.
Growing emphasis on point-of-care (POC) diagnostics
The market is seeing significant growth due to the growing use of point-of-care ultrasonography. It describes how medical professionals utilize ultrasound at the patient's bedside to quickly diagnose and treat patients. These devices allow point-of-care usage even in difficult circumstances since they are small, light, and frequently battery-operated. By reaching underprivileged communities, this increases the accessibility of healthcare overall and addresses unmet healthcare needs. Ultrasound services are now more widely available.
High maintenance and upgradation costs
Ultrasound equipment can be expensive to buy initially, which can be a major barrier for smaller hospitals or those in underdeveloped areas. Healthcare institutions may face financial difficulties due to the requirement for equipment upgrades to stay up with technological breakthroughs and ongoing upkeep. Furthermore, in healthcare settings with limited resources and tight budgets, the high cost of ultrasound instruments may prevent them from being widely available.
The outbreak of COVID-19 has had an overall negative effect on the ultrasound market. The pandemic has generated disruptions in the supply chain of medical devices globally. Some of the major players operating in the market have faced supply chain disruptions especially from distributors in severely impacted emerging countries. On the other hand, the manufacturing capacity of a few players has been affected due to the unavailability of locally sourced raw materials or parts.
The radiology segment is expected to be the largest during the forecast period
The radiology segment is expected to be the largest during the forecast period owing to increasing application of artificial intelligence in radiology. Caption AI technologies can expedite and simplify ultrasonic examinations, enabling more medical personnel to do basic echocardiography exams. This gadget can recognize symptoms of illnesses, including heart failure, in individuals who are at risk anywhere-in hospitals, homes, and other out-of-hospital settings. This reduces hospital stays and improves patient outcomes.
The hospitals segment is expected to have the highest CAGR during the forecast period
The hospitals segment is expected to have the highest CAGR during the forecast period owing to the extensive use of ultrasound devices in hospital settings. The need for ultrasound equipment in OPD and in-patient departments is anticipated to increase with the introduction of portable systems. In addition, a growth in the use of cutting-edge imaging systems and a rise in hospital and industry merger and acquisition activity are probably going to drive up demand for new installations in the upcoming years.
North America is projected to hold the largest market share during the forecast period. The presence of a significant number of competitors in the region and an increasing number of cancer cases are key factors contributing to regional market growth. Increasing expenditure on healthcare, a greater understanding of various methods of diagnosis, and favorable policies for reimbursement are projected to drive regional market growth.
Asia Pacific is projected to hold the highest CAGR over the forecast period owing to the increased demand for better imaging devices. Furthermore, key players are adopting different strategies to strengthen their presence in this region. Factors, such as low research costs, less stringent regulatory guidelines, increased government funding for the R&D sector's development in the respective countries, are making the region attractive for research studies.
Key players in the market
Some of the key players in Ultrasound Equipment market include Philips Healthcare, Canon Medical Systems Corp, Hitachi Healthcare Manufacturing Ltd, Samsung Medison Co Ltd, GE Healthcare, Siemens Healthineers AG, Fujifilm Holdings Corp, Esaote SpA, Mindray, Analogic Corporation, Sonosite, Toshiba Medical Systems and Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
In March 2023, Shenzhen Mindray Bio-Medical Electronics Co., Ltd. launched new handheld ultrasound device TE Air, that provides enhanced point-of-care ultrasound imaging with an array of practical benefits for radiologists.
In February 2022, Koninklijke Philips N.V., launched Lumify, its handheld point-of-care ultrasound solution for expanding its portfolio to offer advanced hemodynamic assessment and measurement capabilities.